ODDITY Tech Ltd.

ODDITY Tech Ltd.

15.55
USD
-2.08
(-11.80%)
0.16EPS
112.73P/E
841.75MMarket Cap
Mar 03Next Earn
ODDITY Tech Ltd.
NASDAQ:ODD
(Nasdaq Stock Market)

Recent

price

15.55

P/E

ratio

112.73

div

yld

- -

ROIC.AI

2020
2021
2022
2023
2024
2025
TTM
USD
2.05
4.13
6.02
9.3
11.28
14.23
13
Revenue per Share
0.22
0.26
0.4
1.07
1.77
1.95
0.17
Basic EPS, GAAP
0.41
0.13
0.67
1.56
2.35
1.47
-0.07
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.93
1.21
1.75
4.98
5.06
6.89
5.72
Book Value per Share
0.83
0.54
0.98
3.2
3.24
5
3.17
Tangible Book Value per Share
54
54
54
55
57
57
52
Basic Weighted Avg Shares
111
223
325
509
647
810
676
Sales/Revenue/Turnover
15.06
8.77
8.52
14.61
17.87
14.67
-2.22
Operating Margin (%)
4
4
4
9
10
13
16
Depreciation Expense
12
14
22
59
101
111
9
Net Income, GAAP
23.99
25.3
24.85
25.53
20.65
18.39
55.37
Effective Tax Rate (%)
10.59
6.25
6.7
11.51
15.69
13.67
1.27
Profit Margin (%)
38
37
56
115
99
487
298
Working Capital
1
- -
8
9
16
602
554
LT Debt
52
81
111
283
282
396
258
Total Equity
- -
20.36
19.59
26.2
30.54
14.81
-0.74
Return on Invested Capital (%)
- -
19.44
20.48
27.71
33.79
16.92
0.95
Return on Capital (%)
- -
23.01
25.97
30.66
35.9
32.63
2.7
Return on Common Equity (%)

Capital Structure

USD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
7
6
5
LT Borrowings
585
537
538
LT Finance Leases
17
16
16
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
57
46
45
Market Capitalization
758
698
842

Working Capital

USD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
500
391
402
Cash, Cash Equivalents & STI
296
193
198
Accounts Receivable, Net
23
12
10
Inventories
148
152
158
Total Current Liabilities
123
113
103
Payables & Accruals
117
107
98
ST Debt
7
6
5
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
57.4%
40.45%
Free Cash Flow
- -
103.48%
-37.81%
Net Income, GAAP
- -
65.37%
9.12%
Sales/Revenue/Turnover
- -
51.22%
25.16%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
212
193
119
124
647
2025
268
241
148
153
810
2026
198
181
145
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.57
0.79
0.31
0.09
1.77
2025
0.68
0.87
0.31
0.1
1.95
2026
-0.38
0.27
0.24
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Oddity Tech Ltd. (Nasdaq: ODD) operates as a consumer technology company that develops and scales digital-first brands in the beauty, wellness and medical telehealth industries through an AI-driven online platform leveraging data science, machine learning and computer vision. The company offers core products including foundation, concealer, lipstick, mascara, eye, brow and lip makeup; skincare and haircare treatments; supplements; and makeup tools under the IL MAKIAGE and SpoiledChild brands; alongside an expanding portfolio of medical-grade dermatology products such as creams, supplements and cosmetics addressing acne, hyperpigmentation and eczema via its new METHODIQ telehealth platform; with ODDITY LABS biotechnology center deploying AI-based molecule discovery for novel ingredients. Founded in 2013 and headquartered in Tel Aviv, Israel, with additional offices in New York City and a biotechnology lab in Boston, Oddity Tech serves consumers worldwide, primarily in the United States and internationally. Recent developments include the November 2025 launch of the METHODIQ brand and telehealth platform in partnership with board-certified dermatologists for AI-powered personalized skincare; the January 2025 acquisition of Fionic's AI intellectual property and elite research team to enhance predictive modeling and consumer engagement algorithms; and raised full-year 2025 revenue guidance to $806-$809 million reflecting 24-25% growth amid record Q3 results.

Company News

  • Oddity Tech: Recovery Visible, But Growth Isn't Guaranteed Yet

  • These Analysts Boost Their Forecasts On Oddity Tech After Upbeat Q3 Results

  • Oddity Tech (ODD) Q3 Earnings and Revenues Beat Estimates

  • Oddity Tech Ltd. (ODD) Q3 2026 Earnings Call Transcript

  • What ODDITY Tech (ODD) Said on Its Q3 Earnings Call

  • ODDITY Tech Reports Third Quarter 2026 Results Ahead of Plan, Raises Full Year Net Revenue And Adjusted EBITDA Outlook

  • New Strong Buy Stocks for November 4th

  • New Strong Buy Stocks for October 29th

  • ODDITY to Announce Third Quarter 2026 Financial Results on November 11, 2026

  • Baillie Gifford Trims ODDITY Tech Ltd (ODD) Stake -- Shares Look 55% Undervalued on GF Value

  • Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate NDA Resubmission and PDUFA Date of March 25, 2027

  • ImmunoForge to Showcase Proprietary Platform Technologies and Next-Generation Oncology & Phase 2 Clinical Pipelines at BIO-Europe 2026

  • Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate NDA Resubmission and PDUFA Date of March 25, 2027

  • Oddity Tech (ODD) Upgraded to Strong Buy: Here's What You Should Know

  • New Strong Buy Stocks for October 15th

  • Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Granted Orphan Drug Designation in Japan, Further Expanding Global Regulatory Recognition

  • ODDITY Tech Ltd (ODD) Shares Fall 5.1% -- What GF Score of 71 Tells Investors

  • Earnings Estimates Moving Higher for Oddity Tech (ODD): Time to Buy?

  • Oddity Tech: Turnaround Potential And Discounted Debt Value Lever

  • Why Oddity Tech's Stock Skyrocketed 26.5% Today